Abbott Labs looks attractive at current levels of $120, despite the stock rising 2x from levels of $62 it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks an outperformance compared to the S&P which has moved 78% since its March 2020 lows...
